PPD Doubles Personnel For Internal Discovery Of Therapeutic Targets
Executive Summary
PPD has "nearly doubled" the number of full-time equivalents in its discovery unit dedicated to R&D for internal projects, CEO Fred Eshelman, MD, told analysts during an April 17 conference call.